Johnson & Johnson News - October 23, 2026
Johnson & Johnson's Tecvayli Gains Expanded EU Approval as Monotherapy for Multiple Myeloma
The European Commission approved an expanded indication for Johnson & Johnson's Tecvayli (teclistamab). Tecvayli is approved as a monotherapy for adults with...
Johnson & Johnson's Oral Psoriasis Pill Icotyde Gains UK Approval
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Johnson & Johnson's daily oral pill, Icotyde (icotrokinra). The drug treats...
Smith & Nephew Merger Talks With J&J Collapse Over Leadership
Advanced merger talks between Smith & Nephew and Johnson & Johnson’s orthopaedics unit, DePuy Synthes, have collapsed. The reported sticking point was a...